Pedro Marques Ramos

Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition

Cédric Leroy, Pedro Marques Ramos, Karen Cornille et al. · Breast Cancer Research · 2016 · 125 citations · Full text

Medicine, Oncology, Pharmacology +17

Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia

Michael Dickinson, Honar Cherif, Pierre Fenaux et al. · Blood · 2018 · 96 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +4

Thrombopoietin receptor–independent stimulation of hematopoietic stem cells by eltrombopag

Yun-Ruei Kao, Jiahao Chen, Swathi-Rao Narayanagari et al. · Science Translational Medicine · 2018 · 71 citations · Full text

Life Sciences, Cell Biology, Hematology +13

Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival

Oscar Brück, Olli Dufva, Helena Hohtari et al. · Blood Advances · 2020 · 67 citations · Full text

Medicine, Hematology, Oncology +16

Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial

Amer M. Zeidan, Kiyoshi Ando, Odile Beyne Rauzy et al. · The Lancet Haematology · 2023 · 67 citations

Medicine, Pharmacology, Pharmacotherapy +10